Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Podcast

IBD Drive Time: Ed Barnes, MD, on AGA Guidelines on Pouchitis

02/21/2024

Dr Ed Barnes joins host Dr Raymond Cross to review the new guidelines from AGA on the treatment of pouchiitis among patients who have undergone ileal pouch-anal anastamosis surgery. 

 

Raymond Cross, MD, is a professor of medicine and director of the IBD Program at the University of Maryland School of Medicine in Baltimore. Edward Barnes, MD, is an assistant professor of medicine and associate director of the Gastroenterology and Hepatology Fellowship Program at the University of North Carolina School of Medicine at Chapel Hill, North Carolina,

 

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the AIBD Network or HMP Global, its employees, and affiliates. 
 

Advertisement

Latest News

fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network
News
Shared Gut Dysbiosis in Crohn’s Disease, Spondyloarthritis, & Acute Anterior Uveitis
03/06/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The gut microbiome represents a promising avenue to understand shared and distinct pathophysiology among patients with immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders.
The gut microbiome represents a promising avenue to understand shared and distinct pathophysiology among patients with immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders.
The gut microbiome represents a...
03/06/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
02/23/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
02/23/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Bowel Urgency Reflected in Patient Perceptions of UC Severity
02/20/2024
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the severity of their ulcerative colitis is affected by the frequency of bowel urgency episodes and accidents, researchers reported at the American College of Gastroenterology Postgraduate Course.
How patients perceive the...
02/20/2024
Advances in Inflammatory Bowel Disease Network
News
Could Polygenic Risk Score Indicate Risk of Primary Sclerosing Cholangitis in IBD?
02/15/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers investigated a new tool that could help predict primary sclerosing cholangitis, a chronic liver disease that is strongly associated with IBD.
Researchers investigated a new tool that could help predict primary sclerosing cholangitis, a chronic liver disease that is strongly associated with IBD.
Researchers investigated a new...
02/15/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

Millie Long
Podcast
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
05/10/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
05/10/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jimmy Limdi, MD, on the Best of ECCO
04/22/2024
In this episode of IBD Drive Time, Dr Raymond Cross hosts Dr Jimmy Limdi from the University of Manchester to discuss his choices for the best presentations and abstracts presented at the European Crohn's and Colitis Organization meeting held...
In this episode of IBD Drive Time, Dr Raymond Cross hosts Dr Jimmy Limdi from the University of Manchester to discuss his choices for the best presentations and abstracts presented at the European Crohn's and Colitis Organization meeting held...
In this episode of IBD Drive...
04/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Patrick Young, MD, on Ergonomics and Endoscopy
03/29/2024
Dr Patrick Young, from the Uniformed Services University and Walter Reed National Military Medical Center in Washington, DC, provides guidance in how to prevent injury and discomfort when performing endoscopy in this episode of IBD Drive Time...
Dr Patrick Young, from the Uniformed Services University and Walter Reed National Military Medical Center in Washington, DC, provides guidance in how to prevent injury and discomfort when performing endoscopy in this episode of IBD Drive Time...
Dr Patrick Young, from the...
03/29/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcasts
IBD Drive Time: Corey Siegel, MD, on Caring for the Patient with Acute Severe UC
03/20/2024
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive...
03/20/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Millie Long, MD, on Insurance Barriers to IBD Care
03/14/2024
Dr Millie Long and her IBD Drive Time cohost, Dr Raymond Cross, talk about ways health insurers create barriers to timely treatment for inflammatory bowel disease, particularly through requirements for prior authorization.
Dr Millie Long and her IBD Drive Time cohost, Dr Raymond Cross, talk about ways health insurers create barriers to timely treatment for inflammatory bowel disease, particularly through requirements for prior authorization.
Dr Millie Long and her IBD Drive...
03/14/2024
Advances in Inflammatory Bowel Disease Network
Podcast
Ryan Ungaro, MD, and Priscila Santiago, MD, on Risk Factors Predictive of Complicated IBD
03/11/2024
In this podcast, Drs Ryan Ungaro and Priscila Santiago discuss their study of risk factors that may be predicators of complications among patients with IBD.
In this podcast, Drs Ryan Ungaro and Priscila Santiago discuss their study of risk factors that may be predicators of complications among patients with IBD.
In this podcast, Drs Ryan Ungaro...
03/11/2024
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Video
Raymond Cross, MD: Define UC Disease Severity in Regard to Symptoms
02/26/2024
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights...
02/26/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Ed Barnes, MD, on AGA Guidelines on Pouchitis
02/21/2024
Dr Ed Barnes from University of North Carolina at Chapel Hill discusses the new guidelines from AGA on the treatment of pouchiitis among patients who have undergone ileal pouch-anal anastamosis surgery.
Dr Ed Barnes from University of North Carolina at Chapel Hill discusses the new guidelines from AGA on the treatment of pouchiitis among patients who have undergone ileal pouch-anal anastamosis surgery.
Dr Ed Barnes from University of...
02/21/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement